DE1153020B - Process for the preparation of phenthiazine derivatives - Google Patents

Process for the preparation of phenthiazine derivatives

Info

Publication number
DE1153020B
DE1153020B DEE17472A DEE0017472A DE1153020B DE 1153020 B DE1153020 B DE 1153020B DE E17472 A DEE17472 A DE E17472A DE E0017472 A DEE0017472 A DE E0017472A DE 1153020 B DE1153020 B DE 1153020B
Authority
DE
Germany
Prior art keywords
phenthiazine
derivatives
preparation
dimethylaminopropyl
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEE17472A
Other languages
German (de)
Inventor
Josef Schmitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clin Byla SA
Original Assignee
Clin Byla SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clin Byla SA filed Critical Clin Byla SA
Publication of DE1153020B publication Critical patent/DE1153020B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Die Erfindung betrifft ein Verfahren zur Herstellung neuer Phenthiazinderivate mit wertvollen Eigenschaften.The invention relates to a method for producing new phenthiazine derivatives with valuable Properties.

Es ist bekannt, daß Phenthiazinderivate, insbesondere das S-Chlor-lO-iy-dimethylaminopropyl)-phenthiazin, sich in der Therapie zur Potenzierung der Narkose, Analgesie und Lokalanästhesie wie auch wegen ihrer hypothermischen, adrenolytischen und Antischockwirkung bewährt haben. Das 3-Chlor-10-(y-dimethylaminopropyl)-phenthiazin ist ein Glied der Reihe der 10-(Dimethylaminoalkyl)-phenthiazine mit Substituenten in der 3-Stellung des Phenthiazinrings, die gegenüber der Einwirkung alkalischer Reagentien, wie Natriumamid, Natriummetall, Natriumhydroxyd, wasserfreies Natriumcarbonat, d. h. gegenüber Reagenzien, die nach den üblichen Verfahren für die Bindung einer Dimethylaminoalkylgruppe an das Stickstoffatom des Phenthiazins verwendet werden, unempfindlich sind. Die gleichzeitige Anwesenheit von Substituenten, wie OH, CHO, COOCH3, COOC2H5, macht jedoch diese Umsetzung im alkalischen Milieu unmöglich.It is known that phenthiazine derivatives, in particular S-chloro-10-iy-dimethylaminopropyl) -phenthiazine, have proven themselves in therapy for potentiating narcosis, analgesia and local anesthesia as well as because of their hypothermic, adrenolytic and anti-shock effects. The 3-chloro-10- (γ-dimethylaminopropyl) -phenthiazine is a member of the series of 10- (dimethylaminoalkyl) -phenthiazines with substituents in the 3-position of the phenthiazine ring, which are resistant to the action of alkaline reagents such as sodium amide, sodium metal, sodium hydroxide , anhydrous sodium carbonate, ie, are insensitive to reagents which are used according to the usual methods for binding a dimethylaminoalkyl group to the nitrogen atom of the phenthiazine. The simultaneous presence of substituents such as OH, CHO, COOCH 3 , COOC 2 H 5 , however, makes this reaction impossible in an alkaline medium.

Es wurde nun gefunden, daß sich wertvolle neue 10-Dialkylaminoalkyl)-phenthiazinderivate der allgemeinen Formel: asIt has now been found that valuable new 10-dialkylaminoalkyl) -phenthiazine derivatives of the general Formula: as

Verfahren zur Herstellung
von Phenthiazinderivaten
Method of manufacture
of phenthiazine derivatives

in der R eine α-Oxyalkylgruppe, A einen geraden oder verzweigten Alkylenrest und R' und R" niedermolekulare Alkylgruppen bedeuten, dadurch herstellen lassen, daß man entsprechende 3-Acyl-phenthiazinderivate mit Lithiumaluminiumhydrid in an sich bekannter Weise reduziert.in which R is an α-oxyalkyl group, A is a straight group or branched alkylene radical and R 'and R "mean low molecular weight alkyl groups, thereby producing let that corresponding 3-acyl-phenthiazine derivatives with lithium aluminum hydride in reduced in a known manner.

Die Ausgangssubstanzen für diese Umsetzung können durch Decarboxylierung der entsprechenden 3 - Acyl - phenthiazin -10 - carbonsäure - dialkylaminoalkylester hergestellt werden, z. B. aus dem y-Dimethylaminopropylester der 3-Acetyl- und der 3-Propionyl-phenthiazin-lO-carbonsäure, ferner aus dem y-Diäthylaminopropylester der 3-Acetyl- und der 3-Propionyl-phenthiazin-lO-carbonsäure oder aus dem jö-Dimethylaminoäthyl-ester der 3-Acetylphenthiazin-10-carbonsäure. The starting substances for this reaction can by decarboxylation of the corresponding 3-acyl-phenthiazine -10-carboxylic acid dialkylaminoalkyl esters can be prepared, e.g. B. from the γ-dimethylaminopropyl ester the 3-acetyl and 3-propionyl-phenthiazine-10-carboxylic acid, also from the y-diethylaminopropyl ester of 3-acetyl and the 3-propionyl-phenthiazine-10-carboxylic acid or from the jo-dimethylaminoethyl ester of 3-acetylphenthiazine-10-carboxylic acid.

Die erfindungsgemäß herstellbaren Verbindungen haben vorzügliche therapeutische Eigenschaften; Anmelder:
Etablissements CLIN-BYLA, Paris
The compounds which can be prepared according to the invention have excellent therapeutic properties; Applicant:
Establishments CLIN-BYLA, Paris

Vertreter: Dr. phil. Dr. rer. pol. Kurt Köhler,
Patentanwalt, München 2, Amalienstr. 15
Representative: Dr. phil. Dr. rer. pole. Kurt Koehler,
Patent attorney, Munich 2, Amalienstr. 15th

Beanspruchte Priorität:
Frankreich vom 30. Juni 1955 (Nr. 694 883)
Claimed priority:
France of June 30, 1955 (No. 694 883)

Josef Schmitt, L'Hay-les-Roses, Seine (Frankreich), ist als Erfinder genannt wordenJosef Schmitt, L'Hay-les-Roses, Seine (France), has been named as the inventor

ihre hypothermischen und depressiven Effekte auf die Nervenzentren sind gut; außerdem zeigen sie als solche eine hypnotische Wirkung, die z. B. das 3 - Chlor -10 - - dimethylaminopropyl) - phenthiazin nicht besitzt.its hypothermic and depressive effects on nerve centers are good; in addition, they show as such a hypnotic effect that z. B. the 3 - chlorine -10 - - dimethylaminopropyl) - phenthiazine does not have.

Die neuen Verbindungen werden schneller wieder ausgeschieden als 3-Chlor-10-(y-dimethylaminopropyl)-phenthiazin. The new compounds are excreted more quickly than 3-chloro-10- (γ-dimethylaminopropyl) -phenthiazine.

Die neuen Verbindungen zeichnen sich durch gute Verträglichkeit und das Fehlen der bei den anderen bekannten Neuroplegjca häufig auftretenden Nebenwirkungen, wie Herzklopfen, Trockenheit des Mundes, aus.The new compounds are characterized by good compatibility and the lack of in the other known Neuroplegjca side effects, such as palpitations, dryness of the Mouth, out.

Beispielexample

a) Hydrochlorid des y-Dimethylaminopropylesters der 3-Acetyl-phenthiazin-lO-carbonsäurea) Hydrochloride of γ-dimethylaminopropyl ester of 3-acetyl-phenthiazine-10-carboxylic acid

In einen mit Chlorcalciumrohr versehenen Kolben werden 30 g 3-Acetyl:phenthiazin-10-carbonsäurechlorid und 11g (5% Überschuß) y-Dimethylaminopropanol in 100 ecm wasserfreiem Aceton eingebracht. Anstatt Aceton kann auch ein anderes wasserfreies organisches Lösungsmittel, z. B. Benzol, benutzt werden. Die Mischung wird eine Nacht unter Rückfluß erhitzt. Es bildet sich ein klarer beigefarbener Niederschlag des Hydrochloride des y-Dimethylaminopropylesters der 3-Acetyl-phenthiazin-10-carbonsäure, der abgetrennt, mit Äther gewaschen und getrocknet wird. Ausbeute: 30g. 30 g of 3-acetyl: phenthiazine-10-carboxylic acid chloride and 11 g (5% excess) of γ-dimethylaminopropanol in 100 ecm of anhydrous acetone are introduced into a flask fitted with a calcium chloride tube. Instead of acetone, another anhydrous organic solvent, e.g. B. benzene can be used. The mixture is refluxed one night. A clear beige-colored precipitate of the hydrochloride of γ-dimethylaminopropyl ester of 3-acetyl-phenthiazine-10-carboxylic acid forms, which is separated off, washed with ether and dried. Yield: 30g.

309 668/318309 668/318

Aus absolutem Äthanol umkristallisiert schmilzt das Hydrochlorid unter Zersetzung bei 213 bis 215°C.Recrystallized from absolute ethanol, the hydrochloride melts with decomposition at 213 to 215 ° C.

b) 3-Acetyl-10-(y-dimethylaminopropyl)-phenthiazinb) 3-acetyl-10- (γ-dimethylaminopropyl) -phenthiazine

30 g des Hydrochloride des nach a) erhaltenen basischen Esters werden in Wasser gelöst und die Base mit χ/ιο normaler kaustischer Sodalösung freigesetzt. Die Base, der y-Dimethylaminopropylester der 3-Acetyl-phenthiazin-lO-carbonsäure, wird mit Äther extrahiert, die ätherische Lösung wird mit Wasser gewaschen und mit Natriumsulfat getrocknet. Nach Verdampfen des Äthers im Wasserbad werden 21 g eines roten Öles erhalten, das in 42 ecm Dekahydronaphthalin gelöst wird. Anstatt Dekahydronaphthalin kann auch eine gleiche Menge anderer Lösungsmittel verwendet werden, z. B. 1,3-Dimethoxybenzol, Chinolin oder Collidin. Die Lösung wird unter Rückfluß erhitzt, bis kein CO2 mehr entweicht. Nach dem Abkühlen wird wieder mit Äther behandelt und mit verdünnter Salzsäure extrahiert. Die Lösung des Hydrochloride wird mit x/io normaler kaustischer Sodalösung versetzt und die Base mit Äther extrahiert. Die ätherische Lösung wird mit Wasser gewaschen und mit Natriumsulfat getrocknet. Nach Abscheiden des Lösungsmittels werden 16 g eines orangefarbenen Öles erhalten, das als Ausgangssubstanz für das erfindungsgemäße Verfahren dient. Auf Säurechlorid bezogen beträgt die Ausbeute 50°/o, auf das Hydrochlorid des basischen Esters bezogen 78%.30 g of the hydrochloride of the basic ester obtained according to a) are dissolved in water and the base is released with χ / ιο normal caustic soda solution. The base, the γ-dimethylaminopropyl ester of 3-acetyl-phenthiazine-10-carboxylic acid, is extracted with ether, the ethereal solution is washed with water and dried with sodium sulfate. After evaporation of the ether in a water bath, 21 g of a red oil are obtained, which is dissolved in 42 ecm of decahydronaphthalene. Instead of decahydronaphthalene, an equal amount of other solvents can also be used, e.g. B. 1,3-dimethoxybenzene, quinoline or collidine. The solution is refluxed until no more CO2 escapes. After cooling, it is treated again with ether and extracted with dilute hydrochloric acid. The solution of the hydrochloride is mixed with x / io normal caustic soda solution and the base is extracted with ether. The ethereal solution is washed with water and dried with sodium sulfate. After the solvent has been separated off, 16 g of an orange-colored oil are obtained, which is used as the starting substance for the process according to the invention. Based on the acid chloride, the yield is 50%, based on the hydrochloride of the basic ester, 78%.

c) 3-(a-Oxyäthyl)-10-(y-dimethylaminopropyl)-phenthiazin und dessen saures Oxalatc) 3- (α-Oxyethyl) -10- (γ-dimethylaminopropyl) -phenthiazine and its acid oxalate

In einen 3-Hals-Kolben, der mit einem mechanischen Rührer mit Quecksilberdichtung, einem aufsteigenden Kühler, Tropftrichter und Stickstoffeinleitungsrohr versehen ist, werden 0,5 g Lithiumaluminiumhydrid und 50 ecm wasserfreier Äther eingebracht und nach und nach eine Lösung von 5 g 3-Acetyl-10-(y-dimethylaminopropyl)-phenthiazin in 50 ecm wasserfreiem Äther zugefügt. Die Lösung entfärbt sich. Eine Viertelstunde nach Beendigung .der Zugabe wird Äthylacetat tropfenweise zugegeben, um den Überschuß an Hydrid zu zersetzen, mit ver- · dünnter kaustischer Sodalösung bis zur Auflösung des Aluminiumniederschlags versetzt, abdekantiert,In a 3-necked flask with a mechanical Stirrer with mercury seal, a rising condenser, dropping funnel and nitrogen inlet tube is provided, 0.5 g lithium aluminum hydride and 50 ecm anhydrous ether introduced and gradually a solution of 5 g of 3-acetyl-10- (γ-dimethylaminopropyl) -phenthiazine added in 50 ecm anhydrous ether. The solution becomes discolored. A quarter of an hour after finishing ethyl acetate is added dropwise to the addition in order to decompose the excess of hydride, with diluted caustic soda solution until the aluminum precipitate dissolves, decanted off,

mit Äther extrahiert und mit Wasser gewaschen. Nach Trocknen der ätherischen Lösung und Destillation werden mit quantitativer Ausbeute 5 g eines rosafarbigen Öles erhalten. Durch Behandeln dieses Öles mit Oxalsäure in Aceton und Umkristallisierung des Produktes aus Aceton wird das saure Oxalat, das bei 139 bis 1410C schmilzt, erhalten.extracted with ether and washed with water. After drying the essential solution and distillation, 5 g of a pink oil are obtained with quantitative yield. By treating this oil with oxalic acid in acetone and recrystallizing the product from acetone, the acidic oxalate, which melts at 139 to 141 ° C., is obtained.

C19H24ON2SC2H2O4:C19H24ON2SC2H2O4:

Berechnet ... C 60,28, H 6,22, N 6,70, S 7,65%; gefunden ... C 60,6, H 6,7, N 6,55, S 7,29%.Calculated ... C 60.28, H 6.22, N 6.70, S 7.65%; Found ... C 60.6, H 6.7, N 6.55, S 7.29%.

Die Herstellung der Ausgangssubstanzen wird nicht beansprucht.The production of the starting substances is not claimed.

Claims (1)

PATENTANSPRUCH:PATENT CLAIM: Verfahren zur Herstellung von Phenthiazinderivaten der allgemeinen FormelProcess for the preparation of phenthiazine derivatives of the general formula in der R eine a-Oxyalkylgruppe, A einen geraden oder verzweigten Alkylenrest und R' und R" niedermolekulare Alkylgruppen bedeuten, dadurcL gekennzeichnet, daß man entsprechende 3-Acylphenthiazinderivate mit Lithiumaluminiumhydrid in an sich bekannter Weise reduziert.in which R is an α-oxyalkyl group, A is a straight or branched alkylene radical and R 'and R "are low molecular weight alkyl groups, characterized in that corresponding 3-acylphenthiazine derivatives are reduced with lithium aluminum hydride in a manner known per se. In Betracht gezogene Druckschriften: Schweizerische Patentschrift Nr. 298 685;Documents considered: Swiss Patent No. 298 685; Journal of the Organic Chemistry, Bd. 19 (1954), S. 1115. Journal of the Organic Chemistry, 19: 1115 (1954).
DEE17472A 1955-06-30 1956-05-04 Process for the preparation of phenthiazine derivatives Pending DE1153020B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR694883 1955-06-30

Publications (1)

Publication Number Publication Date
DE1153020B true DE1153020B (en) 1963-08-22

Family

ID=8701324

Family Applications (2)

Application Number Title Priority Date Filing Date
DEE17472A Pending DE1153020B (en) 1955-06-30 1956-05-04 Process for the preparation of phenthiazine derivatives
DE19561420035 Pending DE1420035B1 (en) 1955-06-30 1956-05-04 Process for the preparation of phenthiazine derivatives with basic substitution in the 10-position

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19561420035 Pending DE1420035B1 (en) 1955-06-30 1956-05-04 Process for the preparation of phenthiazine derivatives with basic substitution in the 10-position

Country Status (4)

Country Link
DE (2) DE1153020B (en)
DK (1) DK103299C (en)
ES (1) ES228143A1 (en)
GB (1) GB816582A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH298685A (en) * 1951-06-28 1954-05-15 Rhone Poulenc Chemicals Process for the preparation of a novel derivative of phenothiazine.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE939630C (en) * 1953-10-25 1956-03-01 Basf Ag Process for the preparation of heterocyclic compounds with a ring-shaped imino group substituted by basic groups

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH298685A (en) * 1951-06-28 1954-05-15 Rhone Poulenc Chemicals Process for the preparation of a novel derivative of phenothiazine.

Also Published As

Publication number Publication date
ES228143A1 (en) 1956-06-16
DE1420035B1 (en) 1970-01-29
GB816582A (en) 1959-07-15
DK103299C (en) 1965-12-13

Similar Documents

Publication Publication Date Title
DE928345C (en) Process for the preparation of 10- (3'-pyrrolidino-propyl) -phenthiazine and its salts or its quaternary ammonium compounds
DE1967162C3 (en) 5-methoxytetralone (1) derivatives, process for their preparation and their use
DE2745598A1 (en) ARYL SULFUR COMPOUNDS, THE PROCESS FOR THEIR MANUFACTURING AND THE PHARMACEUTICAL AGENT CONTAINING THEM
DE1055007B (en) Process for the preparation of 3-aminothiophene-2-carboxylic acid esters and the corresponding free carboxylic acids
DE1153020B (en) Process for the preparation of phenthiazine derivatives
DE1229526B (en) Process for the preparation of delta 4,1-3-oxo-11beta-hydroxy-19-nor-steroids by introducing oxygen in the 11-position by chemical means
DE1952800C3 (en) 3,6-dimethyl-1,2,3,4,4a, 9a-hexahydro-gamma-carboline dihydrochloride
DE936091C (en) Process for the preparation of 3- (p-oxy-substituted phenyl) -cyclohexanoic or -cyclohexencarboxylic acids and their esters
DE2513803A1 (en) BICYCLIC HYDROCARBON DERIVATIVES, METHOD FOR MANUFACTURING AND USING them
DE949232C (en) Process for the production of therapeutically valuable basic substituted acetic acid esters
AT263749B (en) Process for the preparation of dibenzocycloheptaene derivatives and their acid addition salts
DE957123C (en) Process for the production of colchicine thioabules
AT155800B (en) Process for the production of diamino alcohols.
AT227266B (en) Process for the preparation of new phenothiazine derivatives, as well as their acid addition salts and quaternary salts
AT212313B (en) Process for the production of new, N-substituted 2-phenyl-7-amino-alkoxy-chromones
AT211829B (en) Process for the preparation of new 3-aminothiophene-2-carboxylic acid esters and the corresponding free carboxylic acids
DE701901C (en) Process for the preparation of thioformamide compounds
AT251565B (en) Process for the production of new carboxylic acids
DE2236005C3 (en) Dibenzagonal bracket on d, square bracket for -dioxepin- square bracket for 1.3 square bracket for -derivatives and their pharmacologically acceptable salts, as well as processes for their production and pharmaceuticals containing them
AT349030B (en) PROCESS FOR THE PRODUCTION OF NEW 8-HYDROXY-3-HALOGENMETHYL-4-ACETOXY-10-METHYLENE-2,9-DIOXATRICYCLO (4,3,1,03,7) DECANES OR OF THE APPROPRIATE 8-OXO DERIVATIVES
AT336592B (en) PROCESS FOR PREPARING NEW 3- (4- BIPHENYLYL) BUTTER ACIDS, THEIR ESTERS, AMIDES AND SALT
AT205038B (en) Process for the preparation of new 11-oxo-dibenzo- [b, f] -thia- [1] -aza- [4] -cycloheptadiene- [2,6] compounds which are substituted in the 10-position
AT226708B (en) Process for the preparation of the new 4- [5 '- (4 "-Hydroxypiperidino) -pentyl- (2')] - amino-7-chloroquinoline
AT226710B (en) Process for the preparation of new dihydroquinoxalones (2) and their salts
AT143315B (en) Process for the preparation of quinoline derivatives.